Searched for
PRATIBHA PILGAONKAR
Rubicon Research raises Rs 619 crore from anchor investors ahead of IPO launchRubicon Research has secured Rs 619 crore from anchor investors, including global giants like Goldman Sachs, ahead of its Rs 1,377.5 crore ...- TIMF Holdings, 360 ONE Funds invest Rs 140 cr in Rubicon Research ahead of IPORubicon Research secured Rs 140 crore from TIMF Holdings and 360 ONE funds before its IPO. General Atlantic Singapore RR Pte transferred sh...
- Amansa Investments pumps Rs 250 cr in Rubicon Research in pre-IPO funding round; issue by year-endAmansa Investments Ltd has invested Rs 250 crore in pharma formulation firm Rubicon Research Ltd through a pre-initial public offering (IPO...
- General Atlantic to acquire Rubicon as Everstone Cap exitsThe acquisition would mark General Atlantic’s renewed focus on pharma, the buyout major having also backed Jubilant Lifesciences.
- Everstone Capital invests Rs 220 crore in Rubicon ResearchThe $33 million investment, which has both, primary and secondary components, will also provide Kotak Private Equity, an early investor in ...
- Everstone Capital invests Rs 220-cr in RubiconEvertsone Capital, a mid-market equity firm, is stepping up its deal-making pace and with this investment in Rubicon, a contract research a...
- Everstone buys Mumbai-based drug tech firm Rubicon for Rs 220-croreThe India and Southeast Asia-focused Everstone has assets under management of USD3.3 billion and is headquartered in Singapore.
- Kotak Private Equity may exit Rubicon with 3x returnsRubicon Research will also raise primary capital by selling another 20-25% through this round of fundraising that values the company at $20...
- Govt puts clinical research approvals on fast laneThe government has begun speeding up approvals in the area of clinical research which is set to boom in India.
- Kotak PE invests in Rubicon ResearchKotak Private Equity said on Tuesday that it has invested in Rubicon Research, a product development company.
- Indian Pharma Industry: In the pink of healthInnovation, international partnerships, collaborations, inflow of funds, clinical trials partnerships and co-development deals are changing...
Load More
